Patel Kinnari
SEC CIK 1725929 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | See Remarks | 441.9K | $99.2K | $571.6K | 20 | 2022-02-14 | 2025-05-20 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Patel Kinnari made no open-market trades at RCKT in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $6.45 | -767 | 441.9K | -0.2% | -$4,947 | |
| 2025-05-20 | 2025-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $6.53 | -1,409 | 442.7K | -0.3% | -$9,201 | |
| I | 2025-04-10 | 2025-04-09 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | P - Purchase | $4.70 | +21.1K | 26.8K | +372% | +$99.2K |
| 2025-02-25 | 2025-02-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $10.58 | -6,078 | 444.1K | -1% | -$64.3K | |
| D | 2025-02-13 | 2025-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | A - Grant | $0.00 | +57.8K | 450.2K | +15% | $0 |
| 2024-11-25 | 2024-11-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $13.05 | -4,588 | 392.4K | -1% | -$59.9K | |
| 2024-08-20 | 2024-08-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $18.50 | -3,989 | 397.0K | -1.0% | -$73.8K | |
| D | 2024-05-20 | 2024-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale+OE | $23.35 | -4,046 | 401.0K | -1.0% | -$94.5K |
| DM | 2024-05-20 | 2022-02-14+ | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | J - Other | $0.00 | +103.2K | 313.8K | +49% | $0 |
| DM | 2024-05-20 | 2024-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +9,543 | 296.3K | +3% | $0 |
| D | 2024-02-21 | 2024-02-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $29.84 | -7,132 | 238.3K | -3% | -$212.8K |
| D | 2024-02-21 | 2024-02-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | A - Grant | $0.00 | +33.3K | 271.6K | +14% | $0 |
| D | 2024-02-16 | 2024-02-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +26.2K | 245.5K | +12% | $0 |
| D | 2023-11-16 | 2023-11-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 220.4K | +2% | $0 |
| DI | 2023-10-10 | 2023-10-05 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,333 | 101.6K | +3% | $0 |
| 2023-08-21 | 2023-08-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $15.47 | -1,534 | 216.4K | -0.7% | -$23.7K | |
| D | 2023-08-15 | 2023-08-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 218.0K | +2% | $0 |
| 2023-05-19 | 2023-05-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | S - Sale | $21.38 | -1,330 | 214.0K | -0.6% | -$28.4K | |
| D | 2023-05-16 | 2023-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +3,989 | 215.3K | +2% | $0 |
| DA | 2023-02-22 | 2023-02-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | See Remarks | M - OptEx | $0.00 | +15.7K | 166.6K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations